The forecasted data for cardiovascular system medicine sales in Turkey indicates a declining trend from 2024 to 2028. The values in USD PPP per capita are expected to decrease year-on-year, starting from 19.8 in 2024 and dropping to 18 by 2028. The anticipated yearly variations are: -3.03% in 2025, -2.60% in 2026, -2.14% in 2027, and -1.64% in 2028, showing a consistent downturn. This negative trajectory amounts to an average annual decrease (CAGR) from 2024 to 2028 of approximately -1.94%.
Future trends to watch for include demographic shifts such as an aging population, which could heighten demand for cardiovascular treatments despite the current projected decline. Additionally, technological advancements and healthcare policy changes may impact future sales positively or negatively, and staying attuned to these factors will be critical for accurate forecasting and strategic planning.
